|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gunderson LL: Gastric cancer-patterns of
relapse after surgical resection. Semin Radiat Oncol. 12:150–161.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
D'Angelica M, Gonen M, Brennan MF,
Turnbull AD, Bains M and Karpeh MS: Patterns of initial recurrence
in completely resected gastric adenocarcinoma. Ann Surg.
240:808–816. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Noh SH, Park SR, Yang HK, Chung HC, Chung
IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, et al: Adjuvant
capecitabine plus oxaliplatin for gastric cancer after D2
gastrectomy (CLASSIC): 5-year follow-up of an open-label,
randomised phase 3 trial. Lancet Oncol. 15:1389–1396. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sakuramoto S, Sasako M, Yamaguchi T,
Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi
Y, Imamura H, et al: Adjuvant chemotherapy for gastric cancer with
S-1, an oral fluoropyrimidine. N Engl J Med. 357:1810–1820. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Becerra AZ, Aquina CT, Mohile SG, Tejani
MA, Schymura MJ, Boscoe FP, Xu Z, Justiniano CF, Boodry CI, Swanger
AA, et al: Variation in delayed time to adjuvant chemotherapy and
disease-specific survival in stage III colon cancer patients. Ann
Surg Oncol. 24:1610–1617. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chavez-MacGregor M, Clarke CA,
Lichtensztajn DY and Giordano SH: Delayed initiation of adjuvant
chemotherapy among patients with breast cancer. JAMA Oncol.
2:322–329. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Japanese Gastric Cancer Association, .
Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric
Cancer. 20:1–19. 2017. View Article : Google Scholar
|
|
9
|
Guideline Committee of the Korean Gastric
Cancer Association (KGCA), Development Working Group & Review
Panel, . Korean Practice Guideline for gastric cancer 2018: An
evidence-based, multi-disciplinary approach. J Gastric Cancer.
19:1–48. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sasako M, Sakuramoto S, Katai H, Kinoshita
T, Furukawa H, Yamaguchi T, Nashimoto A, Fujii M, Nakajima T and
Ohashi Y: Five-year outcomes of a randomized phase III trial
comparing adjuvant chemotherapy with S-1 versus surgery alone in
stage II or III gastric cancer. J Clin Oncol. 29:4387–4393. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bang YJ, Kim YW, Yang HK, Chung HC, Park
YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, et al: Adjuvant
capecitabine and oxaliplatin for gastric cancer after D2
gastrectomy (CLASSIC): A phase 3 open-label, randomised controlled
trial. Lancet. 379:315–321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bang YJ, Van Cutsem E, Fuchs CS, Ohtsu A,
Tabernero J, Ilson DH, Hyung WJ, Strong VE, Goetze TO, Yoshikawa T,
et al: KEYNOTE-585: Phase III study of perioperative chemotherapy
with or without pembrolizumab for gastric cancer. Future Oncol.
15:943–952. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gunduz N, Fisher B and Saffer EA: Effect
of surgical removal on the growth and kinetics of residual tumor.
Cancer Res. 39:3861–3865. 1979.PubMed/NCBI
|
|
14
|
Ono I, Gunji H, Suda K, Iwatsuki K and
Kaneko F: Evaluation of cytokines in donor site wound fluids. Scand
J Plast Reconstr Surg Hand Surg. 28:269–273. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bayraktar UD, Chen E, Bayraktar S, Sands
LR, Marchetti F, Montero AJ and Rocha-Lima CM: Does delay of
adjuvant chemotherapy impact survival in patients with resected
stage II and III colon adenocarcinoma? Cancer. 117:2364–2370. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Des Guetz G, Nicolas P, Perret GY, Morere
JF and Uzzan B: Does delaying adjuvant chemotherapy after curative
surgery for colorectal cancer impair survival? A meta-analysis. Eur
J Cancer. 46:1049–1055. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klein M, Azaquoun N, Jensen BV and Gögenur
I: Improved survival with early adjuvant chemotherapy after colonic
resection for stage III colonic cancer: A nationwide study. J Surg
Oncol. 112:538–543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Biagi JJ, Raphael MJ, Mackillop WJ, Kong
W, King WD and Booth CM: Association between time to initiation of
adjuvant chemotherapy and survival in colorectal cancer: A
systematic review and meta-analysis. JAMA. 305:2335–2342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Colleoni M, Bonetti M, Coates AS,
Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner
J, Collins J, Thürlimann B, et al: Early start of adjuvant
chemotherapy may improve treatment outcome for premenopausal breast
cancer patients with tumors not expressing estrogen receptors. The
International Breast Cancer Study Group. J Clin Oncol. 18:584–590.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shannon C, Ashley S and Smith IE: Does
timing of adjuvant chemotherapy for early breast cancer influence
survival? J Clin Oncol. 21:3792–3797. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang SY, Ahn MS, Song GW, Choi YW, Lee HW,
Jeong SH, Park JS, Cho YK, Han SU, Sheen SS, et al: Does the timing
of adjuvant chemotherapy for gastric cancer influence patient
outcome? Acta Oncol. 54:1231–1234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park HS, Jung M, Kim HS, Kim HI, An JY,
Cheong JH, Hyung WJ, Noh SH, Kim YI, Chung HC and Rha SY: Proper
timing of adjuvant chemotherapy affects survival in patients with
stage 2 and 3 gastric cancer. Ann Surg Oncol. 22:224–231. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee Y, Min SH, Park KB, Park YS, Kim JW,
Ahn SH, Kim JW, Park DJ, Lee KW and Kim HH: Effect of early
adjuvant chemotherapy on survival of advanced gastric cancer
patients: A propensity score-matched analysis. J Gastric Cancer.
18:58–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang SM, Chen YC, Chen WY, Yang LY, Tsan
DL, Tsang NM, Yap WK, Tsai CS, Leung WM, Hong JH, et al: Optimal
timing for postsurgical adjuvant therapy in patients with gastric
cancer: A propensity score matching study. J Cancer. 10:332–340.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujitani K, Kurokawa Y, Takeno A, Endoh S,
Ohmori T, Fujita J, Yamasaki M, Takiguchi S, Mori M and Doki Y;
Osaka University Clinical Research Group for Gastroenterological
Surgery, : Time to initiation or duration of S-1 adjuvant
chemotherapy; which really impacts on survival in stage II and III
gastric cancer? Gastric Cancer. 21:446–452. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamamoto M, Sakaguchi Y, Kinjo N,
Yamaguchi S, Egashira A, Minami K, Ikeda Y, Morita M, Toh Y and
Okamura T: S-1 adjuvant chemotherapy earlier after surgery
clinically correlates with prognostic factors for advanced gastric
cancer. Ann Surg Oncol. 23:546–551. 2016. View Article : Google Scholar
|
|
27
|
Petrelli F, Zaniboni A, Ghidini A, Ghidini
M, Turati L, Pizzo C, Ratti M, Libertini M and Tomasello G: Timing
of adjuvant chemotherapy and survival in colorectal, gastric, and
pancreatic cancer. A systematic review and meta-analysis. Cancers
(Basel). 11:5502019. View Article : Google Scholar
|
|
28
|
Degiuli M, Sasako M, Calgaro M, Garino M,
Rebecchi F, Mineccia M, Scaglione D, Andreone D, Ponti A and Calvo
F; Italian Gastric Cancer Study Group, : Morbidity and mortality
after D1 and D2 gastrectomy for cancer: Interim analysis of the
Italian Gastric Cancer Study Group (IGCSG) randomised surgical
trial. Eur J Surg Oncol. 30:303–308. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Degiuli M, Sasako M, Ponti A and Calvo F:
Survival results of a multicentre phase II study to evaluate D2
gastrectomy for gastric cancer. Br J Cancer. 90:1727–1732. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kubota T, Hiki N, Sano T, Nomura S, Nunobe
S, Kumagai K, Aikou S, Watanabe R, Kosuga T and Yamaguchi T:
Prognostic significance of complications after curative surgery for
gastric cancer. Ann Surg Oncol. 21:891–898. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaito A, Kinoshita T, Shitara K, Shibasaki
H and Nishida T: Timing of initiation of adjuvant chemotherapy for
gastric cancer: A case-matched comparison study of laparoscopic vs.
open surgery. Eur J Surg Oncol. 43:801–807. 2017. View Article : Google Scholar : PubMed/NCBI
|
